NCT Number: NCT02349880
A Shared Decision-making Training for Inpatients With Schizophrenia
"Shared decision-making" is being promoted as a promising approach for engaging patients with schizophrenia in medical decisions and improving satisfaction and adherence.
To implement shared decision-making, both physicians and patients should commit to it and engage in a mutual decision process. Most research, however, has addressed interventions that either focus on the doctors' side (e.g. "communication skills") or on informing patients about treatment options (e.g. "decision aids"). These approaches have been shown to be feasible in clinical practice but had no strong effects on treatment patterns or adherence, possibly because they were insufficient to motivate and enable patients to engage actively in decision-making. Moreover, these interventions still rely on the doctor's willingness to share decisions, which has been shown to vary considerably.
To overcome these limitations and since many patients do not feel competent to participate in decision-making we developed an intervention that focuses on patients' communicative competencies. this intervention, a five session group-training, will be implemented for inpatients suffering from schizophrenia.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age 18-65
- icd diagnosis F2
- sufficient German language skills
Exclusion criteria
- debility
Treatment and study plan
Primary outcomes
-
adherence to antipsychotic medication
Time frame: 12 months
Sponsors and collaborators
Lead sponsor
Technical University of Munich
Other
Registry information
Important dates
- Study start
- 2011
- Primary completion
- 2014
- Study completion
- 2015
- First posted
- Jan 29, 2015
- Registry last updated
- Apr 25, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Illness Management and Recovery for Veterans With Severe Mental Illness
NCT00515671
Mental Disorders, Psychotic Disorders
Indianapolis, Indiana, United States
View Trial DetailsStudy in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
NCT02658357
Mental Disorders, Psychotic Disorders
Hollywood, Florida, United States
View Trial DetailsStudy Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia
NCT00463372
Mental Disorders, Psychotic Disorders
George, South Africa
View Trial DetailsCorrelation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels
NCT01754532
Mental Disorders, Psychotic Disorders
Hod HaSharon, Israel
View Trial Details